Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Cell Culture PD - Parallel System for Cell Culture Process Development

Product Image
Product Description

DASGIP Parallel Bioreactor Systems for process development with animal and insect as well as with human cell lines allow for advanced process control and automation.

Precise control of all relevant process parameters, user-defined profiles and innumerable automation features result in accelerated and highly efficient process development. Industry-leading communication standards support DoE, process historians and comprehensive data management.

Individual systems can be configured with assorted components and software functions to meet specific application requirements:

  • Parallel operation of four, eight or sixteen bioreactors
  • Excellent growth of e.g. CHO, Hybridoma and NS0 cell lines
  • Excellent scalability and reproducibility
  • Support of high cell densities up to 2x10^7 cells per mL
  • Small footprint achieved through using compact stackable modules
  • Predefined recipes for standard applications
  • Full controller scripting for easy scale-up and scale-down
  • Variable speed pump drives
  • Continuous and cyclic perfusion templates
  • Overhead drives
  • Individual temperature control via Heating Blanket and/or Cooling Finger
  • pH control using acid and base or CO2 and base
  • pO2 control with constant gassing or gassing on demand
  • Individual gas mixture from Air, O2, CO2 and N2
  • Thermal Mass Flow controlled gassing
  • Cascaded pO2 control using gas flow rates and oxygen enchrichment
  • Gassing to headspace, sparger and/or overlay
  • Level control and/or anti foam sensor
  • Optional integration to bioprocess analyzer, cell counter, HPLC, etc.
  • In-situ cell growth monitoring (optical density)
Product Cell Culture PD - Parallel System for Cell Culture Process Development
Company DASGIP
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

DASGIP
Rudolf-Schulten-Str. 5 52428 Jülich Germany

Tel: +49 (0)2461-980-0

Email: info@dasgip.de



Scientific News
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
Paper Filter Can Remove Viruses from Water
A new paper filter can purify water from viruses, even the most difficult and contagious.
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
New HIV Vaccine Target Discovered
NIH-Led team have discovered a new vaccine target site on HIV.
Mimicking Evolution to Create Novel Proteins
A study by researchers in the Kuhlman lab offers a new route to design the 'cellular machines' needed to understand and battle diseases.
Antibody Therapy Opens Door to Potential New Treatment for HIV
Researchers at Rockefeller University show how a broadly neutralizing antibody could be used to help fight HIV.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!